Clinical Trial Update: Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on steroid withdrawal and donor-specific anti-HLA antibodies in renal transplant patients; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Complications
• Renal Transplant Rejection

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Other Complication of Kidney Transplant, Renal Transplant Rejection | Phase 4 | Status: COMPLETED | Results posted: 2020-04-14